Synonymes : anthralin|Dithranol|1143-38-0|1,8-Dihydroxyanthrone|Cignolin|1,8-Dihydroxy-9-anthrone|Chrysodermol|Cigthranol|1,8-Dihydroxyanthracen-9(10H)-one|9(10H)-Anthracenone, 1,8-dihydroxy-|Batridol|Psoriacid-Stift|Lasan|Anthra-Derm|1,8-dihydroxy-10H-anthracen-9-one|Drithoscalp|Derobin|DrithoCreme|Batidrol|Psodadrate|Psoriacide|Anthrone, 1,8-dihydroxy-|1,8-DIHYDROXY-9(10H)-ANTHRACENONE|NSC 43970|Anthraderm|Anthraline|Dithranolum|NSC 629313|Dithranolum [INN-Latin]|Zithranol-RR|Anthralin [USP]|Dithranol [INN]|CCRIS 628|Anthralin (Dithranol)|CHEBI:37510|EINECS 214-538-0|UNII-U8CJK0JH5M|NSC-43970|U8CJK0JH5M|NSC-629313|BRN 2054360|CHEMBL46469|CCRIS 5592|DTXSID7024538|Anthralin (USP)|Dithranol (INN)|NSC629313|NSC 403736|BRN 1976792|NCGC00091330-01|1,8-dihydroxy-9,10-dihydroanthracen-9-one|1,8-Dihydroxy-9(10H)-anthracenone;Anthralin|4-06-00-07602 (Beilstein Handbook Reference)|DTXCID504538|CAS-1143-38-0|SR-05000002011|MFCD00053409|cignoline|Prestwick_528|Anthralin, Dithranol|Dithranol ,(S)|Anthrone,8-dihydroxy-|Spectrum_000056|ANTHRADERM (TN)|ANTHRALIN [MI]|DITHRANOL [IARC]|Spectrum2_000111|Spectrum3_000304|Spectrum4_000151|Spectrum5_000820|ANTHRALIN [VANDF]|DITHRANOL [MART.]|Epitope ID:114081|1,8-dihydroxy-9-anthrane|ANTHRALIN [USP-RS]|cid_2202|DITHRANOL [WHO-DD]|DITHRANOL [WHO-IP]|SCHEMBL3197|BSPBio_001868|KBioGR_000622|KBioSS_000436|MLS001332632|MLS002415712|1,8,9-Trihydroxyanthracene;|DivK1c_000021|SPECTRUM1500127|SPBio_000122|DITHRANOL [EP IMPURITY]|DITHRANOL [EP MONOGRAPH]|Dithranol, >=90% (HPLC)|HMS500B03|KBio1_000021|KBio2_000436|KBio2_003004|KBio2_005572|KBio3_001368|NUZWLKWWNNJHPT-UHFFFAOYSA-|ANTHRALIN [USP MONOGRAPH]|NINDS_000021|HMS1920E07|HMS2091K07|HMS2271B09|HMS3715H19|Pharmakon1600-01500127|HY-B0738|NSC43970|9(10H)-Anthracenone,8-dihydroxy-|Tox21_111115|Tox21_201851|Tox21_300290|BDBM50041802|CCG-38920|LS-570|NSC755873|s4590|1,8-dihydroxy-9-(10H)anthracenone|AKOS015914122|Tox21_111115_1|CS-O-01324|DB11157|KS-5183|NSC-755873|IDI1_000021|1,8-Dihydroxy-9(10H)-anthracenone #|NCGC00091330-02|NCGC00091330-03|NCGC00091330-04|NCGC00091330-05|NCGC00091330-07|NCGC00253941-01|NCGC00259400-01|AC-14842|NCI60_004019|SBI-0051286.P003|FT-0625372|C06831|D00233|D97650|AB00051916_07|A803172|EN300-18537628|Q419397|SR-05000002011-1|SR-05000002011-2|W-108602|Dithranol, European Pharmacopoeia (EP) Reference Standard|Anthralin, United States Pharmacopeia (USP) Reference Standard|Anthralin (Dithranol), Pharmaceutical Secondary Standard; Certified Reference Material